Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.01 is 104% above its 4-year average of -0.19, near the low end of its 4-year range (-1.15–36211.42).
As of the fiscal period ended Tuesday, June 30, 2026. 13.75% below its 12-month average of 0.01.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.01.
DEBT TO EQUITY RATIO
0.01
DEBT TO EQUITY RATIO AVG TTM
0.01
DEBT TO EQUITY RATIO AVG 3Y
-0.29
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.75%
CURRENT VS 3Y AVG
+102.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
0.28
median of 700 covered companies
CURRENT VS SECTOR MEDIAN
-97.37%
vs the sector median at left
Translational Development Acquisition Corp.
Market Cap
$266.99M
Debt to Equity Ratio
0.01
TTM Avg
0.01
3Y Avg
-0.29
5Y Avg
N/A
Market Cap
$267.82M
Debt to Equity Ratio
0.03
TTM Avg
0.11
3Y Avg
0.41
5Y Avg
0.39
Market Cap
$266.05M
Debt to Equity Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.95M
Debt to Equity Ratio
0.46
TTM Avg
0.89
3Y Avg
1.04
5Y Avg
1.12
Market Cap
$264.76M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$264.47M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$264.38M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$270.05M
Debt to Equity Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Translational Development Acquisition Corp. (TDAC) | $266.99M | 0.01 | 0.01 | -0.29 | N/A |
| Kingstone Companies, Inc. (KINS)vs › | $267.82M | 0.03 | 0.11 | 0.41 | 0.39 |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.05M | N/A | N/A | N/A | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.95M | 0.46 | 0.89 | 1.04 | 1.12 |
| LCNB Corp. (LCNB)vs › | $268.25M | 0.37 | 0.54 | 0.62 | 0.44 |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.76M | 0.00 | 0.00 | 0.00 | 0.00 |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 0.00 | 0.00 | 0.00 | 0.00 |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | 0.01 | 0.00 | 0.00 | 0.00 |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 0.00 | N/A | N/A | N/A |
Debt/Equity
0.01
Current Ratio
0.06
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.01 |
| 2026-03-31 | 0.00 |
| 2025-12-31 | 0.00 |
| 2025-09-30 | 0.00 |
| 2025-06-30 | 0.03 |
| 2025-03-31 | 0.04 |
| 2024-12-31 | 36211.42 |
| 2024-09-30 | -1.15 |
| 2024-06-30 | -0.86 |
| 2024-03-31 | -0.86 |
| 2023-12-31 | -0.68 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-05-31 | 3.22 |
